Brown Victoria L. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Brown Victoria L.
Program Team Lead
Transactions
- Award
Common Stock
2022-01-21+17,466→ 29,016 total - Award
Stock Option (Right to Buy)
2022-01-21+24,774→ 24,774 totalExercise: $35.46Exp: 2032-01-20→ Common Stock (24,774 underlying)
Footnotes (3)
- [F1]This represents a restricted stock unit grant made on January 21, 2022 that vests 25% annually in equal installments over four years from the date of grant, subject to continued service.
- [F2]Includes 128 shares from 10/29/21 ESPP purchase.
- [F3]This represents a non-qualified stock option grant made on January 21, 2022 that vests over a four year period with 25% vesting one year from grant date and the remaining 75% vesting in equal monthly installments thereafter through the fourth anniversary of the grant date, subject to continued service.